Simulations Plus Acquires Immunetrics to Expand Its Immunology & Oncology Drug Development Capabilities
https://reachmd.com/news/simulations-plus-acquires-immunetrics-to-expand-its-immunology-oncology-drug-development-capabilities/2451538/
[June 20, 2023] Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, t…
ASTRO/ESTRO Release Clinical Guideline for Local Therapy in Oligometastatic NSCLC
https://reachmd.com/news/astroestro-release-clinical-guideline-for-local-therapy-in-oligometastatic-nsclc/2451534/
The American Society for Radiation Oncology (ASTRO) and European Society for Radiotherapy & Oncology (ESTRO) have released the first clinical guideline on the use of definitive local therapy, including radiation and surgery, for the treatment of patients with oligometastatic non–small cell lung c…
Scientists Believe Disorienting the Malaria Parasite May Prevent It from Causing Harm
https://reachmd.com/news/scientists-believe-disorienting-the-malaria-parasite-may-prevent-it-from-causing-harm/2451511/
Form of Plasmodium responsible for the destruction of red blood cells as seen by expansion microscopy. Credit: Vincent Louvel and Eloïse Bertiaux With almost 250 million cases a year, 621,000 of them fa…
UMass Amherst Biostatistician Developing Statistical Tools to Predict Breast Cancer Survival & Inform Targeted Therapies
https://reachmd.com/news/umass-amherst-biostatistician-developing-statistical-tools-to-predict-breast-cancer-survival-inform-targeted-therapies/2451513/
AMHERST, Mass. – Breast cancer is a complex disease, and its progression is difficult, yet important, to predict. While many elements may contribute to a breast cancer prognosis, University of Massachusetts Amherst biostatistician Chi Hyun Lee has zeroed in on one risk factor that has emerged for…
CHOP Researchers Develop Universal MHC Molecules That Can Be Produced Rapidly at Scale
https://reachmd.com/news/chop-researchers-develop-universal-mhc-molecules-that-can-be-produced-rapidly-at-scale/2451502/
--The molecules open the door for development of immunotherapies that are truly universal and work across HLA types, regardless of patient ancestry— PHILADELPHIA, June 13, 2023 /PRNewswire/ -- Class I major histocompatibility complex (MHC-I) proteins play an essential role in the immune system of …
Creating a Sound Basis for Future Healthcare in Europe
https://reachmd.com/news/creating-a-sound-basis-for-future-healthcare-in-europe/2451512/
What could healthcare look like in 10, 20, or 30 years? What will be the future of healthcare? Will medical professionals make diagnoses with the aid of artificial intelligence? Will doctors use big data analytics to predict the course of diseases? Will we stay healthy for longer thanks to state-o…
Daily Multivitamin Supplementation Has a Positive Effect on Key Nutrition Biomarkers in Older Men
https://reachmd.com/news/daily-multivitamin-supplementation-has-a-positive-effect-on-key-nutrition-biomarkers-in-older-men/2451496/
A six-month study of healthy older men demonstrated that daily multivitamin/multimineral supplementation had a positive effect on key nutrition biomarkers. The research led by Oregon State University's Tory Hagen and Alexander Michels also showed that the changes in nutrition statu…
New Research from the Stowers Institute Reveals the Start of Huntington's Disease
https://reachmd.com/news/new-research-from-the-stowers-institute-reveals-the-start-of-huntingtons-disease/2451490/
Stowers scientists deduce the initiating structure of the amyloid implicated in Huntington's and present a potential therapeutic treatment approachKANSAS CITY, Mo., June 13, 2023 /PRNewswire/ -- Devastating neurodegenerative diseases like Huntington's, Alzheimer's, and Parkinson's are all associat…
Myriad Genetics' (MYGN) New Pact to Use MRD Testing Platform
https://reachmd.com/news/myriad-genetics-mygn-new-pact-to-use-mrd-testing-platform/2451495/
Myriad Genetics MYGN recently entered into a research agreement with The University of Texas MD Anderson Cancer Center. Through the collaboration, Myriad will support MD Anderson researchers studying metastatic renal cell carcinoma (RCC) treatment selection and response.The latest project will util…
People Who Preserve ‘Immune Resilience’ Live Longer, Resist Infections
https://reachmd.com/news/people-who-preserve-immune-resilience-live-longer-resist-infections/2451464/
Sunil Ahuja, Muthu Manoharan et al. describe immune resilience to explain why some people, regardless of age, have impact immune systems and reduced inflammation while others do not. The blue-clad spheres are T-cells. The lower sphere is COVID-19 featuring its characteristic red spike proteins. …